Neuraptive Therapeutics

Neuraptive Therapeutics Earns FDA Orphan Drug Designation for Novel Peripheral Nerve Injury Treatment

WAYNE, PA — Neuraptive Therapeutics Inc. recently announced that its novel treatment for peripheral nerve injury, NTX-001, has received Orphan Drug Designation from the United States Food and Drug Administration …

Neuraptive Therapeutics Earns FDA Orphan Drug Designation for Novel Peripheral Nerve Injury Treatment Read More

NRx Pharmaceuticals

NRx Pharmaceuticals’ NRX-101 Receives FDA Fast Track Designation: A Potential Gamechanger for Treating Complex UTIs

RADNOR, PA — In a significant development that could revolutionize the treatment of complicated urinary tract infections (cUTI) and pyelonephritis, NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has received Qualified Infectious Disease …

NRx Pharmaceuticals’ NRX-101 Receives FDA Fast Track Designation: A Potential Gamechanger for Treating Complex UTIs Read More

Food and Drug Administration

Florida Gets Green Light from FDA to Import Prescription Drugs from Canada: A Potential Game-Changer for U.S. Healthcare Costs

The U.S. Food and Drug Administration (FDA) recently authorized Florida’s Agency for Health Care Administration to import certain prescription drugs from Canada under section 804 of the Federal Food, Drug, …

Florida Gets Green Light from FDA to Import Prescription Drugs from Canada: A Potential Game-Changer for U.S. Healthcare Costs Read More


Ocugen

Ocugen’s OCU400 Earns FDA’s RMAT Designation, Enhancing Prospects for Retinitis Pigmentosa Treatment

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a Pennsylvania-based biopharmaceutical company, has scored a significant regulatory milestone this week with the U.S. Food and Drug Administration (FDA) granting Regenerative Medicine …

Ocugen’s OCU400 Earns FDA’s RMAT Designation, Enhancing Prospects for Retinitis Pigmentosa Treatment Read More
West Pharmaceutical Services, Inc. (NYSE: WST)

West Pharmaceutical Services Expands Injectable Drug Portfolio with FDA Cleared Vial2Bag Advanced 13mm Admixture Device

EXTON, PA — In a move that strengthens its position as a global leader in innovative solutions for injectable drug administration systems, West Pharmaceutical Services, Inc. (NYSE: WST) recently announced …

West Pharmaceutical Services Expands Injectable Drug Portfolio with FDA Cleared Vial2Bag Advanced 13mm Admixture Device Read More